3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
2
Recruiting
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
7
INDUSTRY
2
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Esophageal Squamous Cell Carcinoma
1
Interventions
tislelizumab
12
Capecitabine
8
apatinib
5
Surgical Procedures, Operative
5
Carboplatin
5
Oxaliplatin
4
Drug Therapy
4
Cisplatin
4
Radiation
3
Paclitaxel
3
Immunotherapy
3
Bevacizumab
3
toripalimab
2
anlotinib
2
Standard of Care
2
Radiotherapy
2
Methods
2
Melphalan
2
Low-Level Light Therapy
2
Letrozole
2
Interleukin-2
2
Injections
2
Cryotherapy
2
130-nm albumin-bound paclitaxel
2
zanubrutinib
1
trastuzumab deruxtecan
1
sintilimab
1
pyrotinib
1
pertuzumab
1
obinutuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
OTHER_GOV
×
Platinum Compounds
×
Clear all
NCT07629817
2026-06-05
HCHTOG2603
Henan Cancer Hospital
Phase 3
Not yet recruiting
1,044 enrolled